PPI Modulators of E6 as Potential Targeted Therapeutics for Cervical Cancer: Progress and Challenges in Targeting E6

Advanced cervical cancer is primarily managed using cytotoxic therapies, despite evidence of limited efficacy and known toxicity. There is a current lack of alternative therapeutics to treat the disease more effectively. As such, there have been more research endeavors to develop targeted therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitsike, Lennox, Duerksen-Hughes, Penelope J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158384/
https://www.ncbi.nlm.nih.gov/pubmed/34070144
http://dx.doi.org/10.3390/molecules26103004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158384/
https://www.ncbi.nlm.nih.gov/pubmed/34070144
http://dx.doi.org/10.3390/molecules26103004

Ejemplares similares